BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Aug 01, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Hydros-TA: Phase II data

In the double-blind, international Phase II COR1.0 trial in 98 patients with osteoarthritis of the knee, Carbylan said a single intra-articular injection of Hydros or Hydros-TA had "positive results" in pain and function scores and showed the "potential to provide superior pain relief and improved function" vs. a single intra-articular...

Read the full 237 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >